This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Illumina Corporation. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Innovations by Aaron Day in Nucleotide Sequencing Analysis
Introduction
Aaron Day is an accomplished inventor based in San Diego, CA. He has made significant contributions to the field of genetic analysis through his innovative patent. His work focuses on enhancing the efficiency of secondary analyses of nucleotide sequencing data.
Latest Patents
Aaron Day holds a patent for a "System and method for secondary analysis of nucleotide sequencing data." This patent discloses systems and methods for performing secondary analyses in a time-efficient manner. Some embodiments of the invention include performing secondary analysis iteratively while sequence reads are generated by a sequencing system. The secondary analyses can encompass alignment of sequence reads to a reference sequence, such as the human reference genome sequence. This alignment is crucial for detecting differences between a sample and the reference. The secondary analysis enables the detection of genetic differences, variant detection, genotyping, identification of single nucleotide polymorphisms (SNPs), small insertions and deletions (indels), and structural changes in DNA, including copy number variants (CNVs) and chromosomal rearrangements.
Career Highlights
Aaron Day is associated with Illumina Corporation, a leading company in the field of genomics. His work at Illumina has allowed him to contribute to advancements in genetic research and technology. With a focus on improving the efficiency of genetic data analysis, he has positioned himself as a key player in the industry.
Collaborations
Some of Aaron's coworkers include Francisco Jose Garcia and Come Raczy. Their collaboration has likely contributed to the innovative environment at Illumina Corporation, fostering advancements in genetic analysis technologies.
Conclusion
Aaron Day's contributions to nucleotide sequencing analysis through his patent demonstrate his commitment to advancing genetic research. His work at Illumina Corporation continues to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile